GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (FRA:5GV) » Definitions » Short-Term Capital Lease Obligation

Genovis AB (FRA:5GV) Short-Term Capital Lease Obligation : €0.00 Mil (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Genovis AB Short-Term Capital Lease Obligation?

Genovis AB's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €0.00 Mil.

Genovis AB's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€0.47 Mil) but then declined from Dec. 2024 (€0.47 Mil) to Mar. 2025 (€0.00 Mil).

Genovis AB's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (€0.26 Mil) to Dec. 2023 (€0.40 Mil) and increased from Dec. 2023 (€0.40 Mil) to Dec. 2024 (€0.47 Mil).

Genovis AB Short-Term Capital Lease Obligation Historical Data

The historical data trend for Genovis AB's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Short-Term Capital Lease Obligation Chart

Genovis AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.17 0.26 0.40 0.47

Genovis AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.47 -

Genovis AB Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Genovis AB Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Genovis AB's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Genovis AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (FRA:5GV) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
OSTO:HNSA OSTO:VICO OSTO:BINV OSTO:DMYD B OSTO:SANION OSTO:XSPRAY OSTO:EGTX OSTO:SYNACT OSTO:IBT B XSAT:HAMLET B VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
GENO:Sweden
Address
Kavlinge, Box 4, Lund, SWE, SE-24421
Website
https://www.genovis.com
Genovis AB offers customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Its enzyme products, known as SmartEnzymes, are used by scientists all over the world, and the product formats facilitate the development and quality control of biological drugs. Its products include Enzyme and Antibodies. Geographically, it operates in Sweden and Rest of the world.

Genovis AB Headlines

No Headlines